NL192304C - Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. - Google Patents

Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. Download PDF

Info

Publication number
NL192304C
NL192304C NL8700119A NL8700119A NL192304C NL 192304 C NL192304 C NL 192304C NL 8700119 A NL8700119 A NL 8700119A NL 8700119 A NL8700119 A NL 8700119A NL 192304 C NL192304 C NL 192304C
Authority
NL
Netherlands
Prior art keywords
piperazine
pyrrolidone
elem
found
calculated
Prior art date
Application number
NL8700119A
Other languages
English (en)
Dutch (nl)
Other versions
NL192304B (nl
NL8700119A (nl
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of NL8700119A publication Critical patent/NL8700119A/nl
Publication of NL192304B publication Critical patent/NL192304B/xx
Application granted granted Critical
Publication of NL192304C publication Critical patent/NL192304C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
NL8700119A 1986-01-21 1987-01-20 Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. NL192304C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP1135986 1986-01-21
JP1136086 1986-01-21
JP1135986 1986-01-21
JP1136086 1986-01-21
JP17516886 1986-07-24
JP17516886 1986-07-24

Publications (3)

Publication Number Publication Date
NL8700119A NL8700119A (nl) 1987-08-17
NL192304B NL192304B (nl) 1997-01-06
NL192304C true NL192304C (nl) 1997-05-07

Family

ID=27279384

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8700119A NL192304C (nl) 1986-01-21 1987-01-20 Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat.

Country Status (11)

Country Link
US (1) US5102882A (US20050192411A1-20050901-C00001.png)
BE (1) BE1003248A5 (US20050192411A1-20050901-C00001.png)
CA (1) CA1323874C (US20050192411A1-20050901-C00001.png)
CH (1) CH675418A5 (US20050192411A1-20050901-C00001.png)
DE (2) DE3701494A1 (US20050192411A1-20050901-C00001.png)
ES (1) ES2002083A6 (US20050192411A1-20050901-C00001.png)
FR (2) FR2597100A1 (US20050192411A1-20050901-C00001.png)
GB (1) GB2185483B (US20050192411A1-20050901-C00001.png)
IT (1) IT1205715B (US20050192411A1-20050901-C00001.png)
NL (1) NL192304C (US20050192411A1-20050901-C00001.png)
SE (1) SE503436C2 (US20050192411A1-20050901-C00001.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367393A3 (en) * 1988-10-31 1991-03-27 Takeda Chemical Industries, Ltd. New heterocyclic compounds, production and use thereof
IT1244507B (it) * 1991-04-11 1994-07-15 Sigma Tau Ind Farmaceuti Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
FR2680508B1 (fr) * 1991-08-20 1995-03-03 Adir Nouveaux composes amidiques des 1-(alcoxybenzyl)piperazines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5652249A (en) * 1993-07-28 1997-07-29 Nippon Shinyaku Co., Inc. Method of treating depression
GB9420784D0 (en) * 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
EP0869793A4 (en) * 1995-11-13 1999-02-03 Smithkline Beecham Corp HEMOREGULATORY COMPOUNDS
CN1210274C (zh) * 2000-02-11 2005-07-13 沃泰克斯药物股份有限公司 哌嗪和哌啶衍生物
MXPA05003471A (es) * 2002-10-03 2005-07-01 Vertex Pharma Derivados de piperazina y piperadina para el tratamiento de enfermedades neurologicas.
BRPI0806700A8 (pt) 2007-01-12 2019-01-22 Novartis Ag processo
DE102008003828B3 (de) 2008-01-10 2009-09-03 Clariant International Limited Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze
DE102008003826B4 (de) * 2008-01-10 2010-07-22 Clariant International Limited Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze
US8835668B2 (en) 2010-08-23 2014-09-16 Novartis Ag Process for the preparation of intermediates for the manufacture of NEP inhibitors
AU2016278053A1 (en) 2015-06-15 2018-01-04 The Children's Hospital Of Philadelphia Methods of diagnosing and treating autism
CN111936463A (zh) * 2018-01-18 2020-11-13 费城儿童医院 法索拉西坦结晶形式
US11608324B2 (en) * 2018-01-18 2023-03-21 The Children's Hospital Of Philadelphia Solid forms of fasoracetam

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3051722A (en) * 1960-10-21 1962-08-28 Lakeside Lab Inc 5-pyrrolidone-2-carboxamides
JPS5015793B2 (US20050192411A1-20050901-C00001.png) * 1972-06-07 1975-06-07
JPS518266A (en) * 1974-07-10 1976-01-23 Sakai Chemical Industry Co Piroridonjudotaino seizohoho
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
HU180925B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
JPS56147766A (en) * 1980-04-17 1981-11-16 Sakai Chem Ind Co Ltd Preparation of lactam
DE3031118A1 (de) * 1980-08-18 1982-04-01 Meditest Institut für medizinisch-pharmazeutische Untersuchungen GmbH & Co KG, 7958 Laupheim N,n'-bis(5-oxo-1-methyl-pyrrolidin-2-yl-essigsaeure)-hydrazid, verfahren zu dessen herstellung und seine verwendung als arzneimittel
HU184481B (en) * 1981-10-02 1984-08-28 Richter Gedeon Vegyeszet Process for producing tripeptides for diminishing appetite
GB2130590B (en) * 1982-11-10 1986-01-08 Erba Farmitalia Peptides
US4483991A (en) * 1983-01-17 1984-11-20 American Home Products Corporation Hypotensive agents
US4525476A (en) * 1983-05-26 1985-06-25 Warner-Lambert Company N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
IT1172391B (it) * 1983-12-23 1987-06-18 Polifarma Spa Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
NL192304B (nl) 1997-01-06
GB2185483A (en) 1987-07-22
IT1205715B (it) 1989-03-31
IT8747545A0 (it) 1987-01-20
FR2597100A1 (fr) 1987-10-16
CH675418A5 (US20050192411A1-20050901-C00001.png) 1990-09-28
FR2597100B1 (US20050192411A1-20050901-C00001.png) 1994-08-19
SE503436C2 (sv) 1996-06-17
NL8700119A (nl) 1987-08-17
CA1323874C (en) 1993-11-02
BE1003248A5 (fr) 1992-02-11
FR2613366B1 (US20050192411A1-20050901-C00001.png) 1994-08-19
FR2613366A1 (fr) 1988-10-07
SE8700203L (sv) 1987-07-22
US5102882A (en) 1992-04-07
GB8701245D0 (en) 1987-02-25
SE8700203D0 (sv) 1987-01-20
DE3701494A1 (de) 1987-07-23
GB2185483B (en) 1990-10-24
DE3744947C2 (US20050192411A1-20050901-C00001.png) 1992-07-16
ES2002083A6 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
NL192304C (nl) Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat.
US3978045A (en) N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
DK162389B (da) Analogifremgangsmaade til fremstilling af 2-oe4-oe(4,4-dialkyl-2,6-piperidindion-1-yl)butylaa-1-piperazinylaapyrimidiner
CA1242439A (en) 1-¬(AMINOALKYL AND AMINOALKYLAMINO)CARBONYL AND THIOCARBONYL|-.alpha.,.alpha.-DIARYLPYRROLIDINE, PIPERIDINE AND HOMOPIPERIDINEACETAMIDES AND ACETONITRILES
CZ292625B6 (cs) Derivát triazolu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a použití
US5001134A (en) Piperidines, processes of preparation and medications containing them
SE503436C3 (sv) Pyroglutamidderivat
Boegesoe et al. Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity
NO313997B1 (no) Nye N-substituerte sykliske aminer, fremgangsmåte ved fremstilling derav ogfarmasöytiske sammensetninger inneholdende slike
HU208422B (en) Process for producing 1-//diaryl-methoxy/-alkyl/-pyrrolidine- and 1-//diaryl-methoxy/-alkyl/-piperidine derivatives
FI88300B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara diazinylpiperidinderivat av cykliska amider och imider
US5449677A (en) Cyclic benzylamino, benzylamido and benzylimido antipsychotic agents
AU600378B2 (en) Piperidine derivatives, their preparation and their application in therapy
US4826843A (en) Cerebral function enhancing diazinylpiperidine derivatives
SK143096A3 (en) Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
HU179361B (en) Process for preparing indoly-methyl-piperidine derivatives
JP2513197B2 (ja) ピログルタミド誘導体
US4670420A (en) N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
HU194874B (en) Process for the production of derivatives of 1-pirrolidin-2-ons of 1-/2-piramidinil/-piperazinil and medical compositions containg thereof
US5401744A (en) Useful hemi-hydrate form of a cerebral function enhancing agent
FI107151B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2-[4-(4,4-bis(4-fluorifenyyli)butyyli)piperatsin-1-yyli]pyridin-3-yyli-karboksyyliestrereiden valmistamiseksi
KR20080027925A (ko) 신규한 1h­인돌­피리딘카르복스아미드 유도체 및1h­인돌­피페리딘카르복스아미드 및 이들의히드록실라아제 티로신 유도제로서의 용도
AU4856293A (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
JPH01275557A (ja) 1―置換―4―ペンタフルオロフエノキシピペリジン類

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20000801